Injection: 2mg/mL – 5mL Vial Oral: 500mcg – 60 capsules
The recent FDA regulations have impacted the availability of certain substances essential for peptide production by compounding pharmacies. Despite these changes, we are pleased to announce that specific peptides remain available through our services, contingent upon a medical consultation. We appreciate your ongoing support as we adapt to these regulatory adjustments. To discuss your options and continue benefiting from our peptide offerings, please book a consultation with us today.
Semaglutide and Tirzepatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). I hereby declare that I do not have a personal or family history of MTC or MEN 2.
10 mg bottle $155; Oral BPC 157 – 500 mcg 60 capsules $199